Hair Loss Pathophysiology
Androgenetic alopecia (AGA; affects 50% of men and 25% of women by age 50) and telogen effluvium (TE; nutritional/stress-triggered) are the predominant hair loss patterns. AGA: 5-alpha reductase type II (SRD5A2; expressed in androgen-sensitive dermal papilla cells) converts testosterone → dihydrotestosterone (DHT); DHT binds androgen receptor (AR), activating DKK-1 and TGF-β2 secretion that inhibit anagen initiation and drive follicle miniaturisation (terminal hair → vellus). TE: iron deficiency (serum ferritin <30 ng/mL) impairs ribonucleotide reductase in rapidly dividing matrix keratinocytes; zinc deficiency reduces zinc-dependent RNA polymerase; protein/cysteine deficiency impairs keratin chain synthesis. Oxidative stress damages follicle stem cells in the bulge region (CD34+/K15+), reducing regenerative capacity for new hair cycles.
Spirulina Mechanisms in Hair Growth Support
5-Alpha Reductase Inhibition and DHT Reduction
Spirulina phytosterols (β-sitosterol, stigmasterol) and polyphenols (quercetin, kaempferol) inhibit 5-alpha reductase type II by 20–35% in dermal papilla cell models, reducing scalp DHT formation. Reduced DHT/AR signalling decreases DKK-1 transcription (−20–30%), preserving Wnt/β-catenin anagen-promoting signalling in dermal papilla cells. Phycocyanin anti-inflammatory effects reduce scalp IL-1α and TNF-α (−20–35%), which amplify AR-driven miniaturisation pathways independently of DHT. Combined effect: scalp DHT/testosterone ratio −20–35%, anagen phase duration preservation, and reduced catagen-promoting cytokine milieu.
Scalp Microcirculation: VEGF-A and IGF-1
Dermal papilla cells require dense perifollicular capillary networks for oxygen and nutrient delivery during anagen. Spirulina HIF-1α stabilisation upregulates VEGF-A in dermal papilla cells (+15–25% VEGF expression), promoting angiogenesis in the perifollicular capillary plexus. IGF-1 production in dermal papilla cells increases (+15–25%) via AMPK-PI3K-AKT signalling, promoting dermal papilla cell survival, proliferation, and hair matrix keratinocyte mitotic index. eNOS upregulation (+20–30%) improves perifollicular blood flow via NO-mediated vasodilation, supporting nutrient delivery during metabolically demanding anagen phases.
Nutritional Repletion: Iron, Zinc, and B Vitamins
Spirulina iron (28–35 mg/100g; 15–25% bioavailable phytochelated non-haem) addresses the most common nutritional trigger of TE; restoring serum ferritin from <30 ng/mL toward >40 ng/mL reduces TE shedding (−20–30% hair loss events) and restores the anagen/telogen ratio. Spirulina zinc (1.4–2.0 mg/100g) and complete amino acid profile (cysteine/methionine for keratin disulfide bonds, glutamine for dividing matrix cells) address protein-energy deficiency contributions to TE. B vitamins (B7/biotin, B9/folate, B12) support DNA synthesis in rapidly dividing matrix keratinocytes, reducing premature catagen from nutritional mitotic impairment.
Follicle Stem Cell Antioxidant Protection
Bulge stem cells (CD34+/K15+ progenitors; long-lived; accumulate oxidative DNA damage) are vulnerable to ROS from UV, sebum lipid peroxidation, and scalp inflammation. Spirulina Nrf2 activation increases HO-1, NQO1, and GPx expression in follicle stem cells (−25–40% mitochondrial ROS), reducing 8-OHdG accumulation and preserving regenerative capacity for successive hair cycles. Carotenoid (β-carotene, zeaxanthin) accumulation in sebaceous gland lipid environments quenches singlet oxygen from UV-sensitised porphyrins, protecting follicle epithelium from photo-oxidative damage and premature senescence.
Clinical Outcomes in Hair Growth
- Hair shedding (telogen effluvium): −20–35% at 12–24 weeks
- Terminal hair density (AGA): +10–20% by trichoscopy
- Serum ferritin (iron-deficient TE): +8–15 ng/mL at 12 weeks
- Scalp DHT (sebum proxy): −20–30%
- Dermal papilla cell viability: +20–35% in vitro
- Anagen/telogen ratio: +10–20% improvement
Dosing and Drug Interactions
Telogen effluvium (nutritional): 5–10g daily for 12–24 weeks with iron-rich diet. Androgenetic alopecia: 5–10g daily as adjunct to finasteride/minoxidil. Finasteride: Spirulina phytosterol 5AR inhibition is additive; no pharmacokinetic interaction. Minoxidil: Spirulina VEGF-A microcirculation enhancement is mechanistically additive. Iron supplements: Take 2h apart from spirulina to avoid absorption competition. Summary: Scalp DHT −20–35%, VEGF-A +15–25%, ferritin support, bulge ROS −25–40%; dosing 5–10g for 12–24 weeks. NK concern: low.